Navigation Links
Schering-Plough Announces Expanded Stock Retention Guidelines for Senior Management
Date:4/11/2008

KENILWORTH, N.J., April 11 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) announced today a new governance action intended to strengthen the alignment of executives with the interests of shareholders.

"We are expanding the stock retention guidelines, which we believe are now among the strongest in our industry, for the Executive Management Team (including the five highest-paid executives)," said Hans W. Becherer, Chairman of the Compensation Committee of the Board of Directors.

Key elements of the policy are as follows:

-- Going forward, the executives are required to hold shares acquired upon

the exercise of stock options for two years (not including shares used

to pay the exercise price and tax withholding on the exercise).

-- Existing stock ownership guidelines continue in effect. Those

guidelines require the CEO to hold eight times salary in stock and

other senior executives (including the executive vice presidents) to

hold four times salary in stock.

"Schering-Plough executive compensation policies tie a significant percentage of compensation to performance. Further, a significant portion of total executive compensation is already paid in stock (rather than cash) to align management with shareholders. The policy we are announcing today further strengthens that alignment with shareholders, at a time when our industry and our company are under increasing challenge," said Becherer.

"The actions we are announcing today further strengthen our company in a challenging environment, as we continue with confidence to drive toward our goal of long-term high performance," said Fred Hassan, chairman and CEO.

Schering-Plough is an
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Schering-Plough to Webcast Presentation by CEO Fred Hassan at Lehman Brothers Eleventh Annual Global Healthcare Conference
2. Schering-Plough Promotes Ian Mcinnes to President of Global Supply Chain
3. CORRECTED: Hagens Berman Sobol Shapiro Files Suit Against Merck and Schering-Plough
4. Lawsuit Filed in Florida Federal Court Over Marketing of Vytorin and Zetia By Merck and Schering-Plough
5. Schering-Plough CEO to Buy $2 Million in Common Shares
6. Schering-Plough Board Elects Dr. Craig B. Thompson as a Director
7. Centocor, Schering-Plough Revise Agreement Covering REMICADE, Golimumab
8. Schering-Plough Declares Quarterly Dividends on Common Shares and 2007 Mandatory Convertible Preferred Stock
9. Schering-Plough Receives Clearance From U.S. Federal Trade Commission for Planned Acquisition of Organon Biosciences N.V.
10. Schering-Plough to Webcast CFO Robert J. Bertolinis Presentation at 2007 Credit Suisse Health Care Conference
11. Schering-Plough Reports U.S. District Court for District of Massachusetts Finds No Liability for Subsidiary in AWP Case
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/14/2008)... Also debuts TMR,09 campaign, IRVINE, Calif., O...poration (Pink Sheets: CGCP), a global leader of i...nd the market leader of surgical products for,tran...educational symposium,yesterday in conjunction wit...rapeutics (TCT) meeting in Washington, D.C., The ...
(Date:10/14/2008)... more than 500 accounts Company opening new PROMUS...ICK, Mass., Oct. 14 /PRNewswire-FirstCall/ -- Bost...unced estimated U.S. market shares for,September f...liminary data,from Millennium Research Group (MRG)...he healthcare sector., Based on the MRG data, the...
(Date:10/14/2008)... Leading Supplemental Insurance Company Encour... Employee Benefits , Chic...e , a leading provider of supplemental insurance, ...time to review employee benefits and recommends ,V...to help retain employees. These programs can be a ...
(Date:10/14/2008)...ctober 14 /PRNewswire/ -- Researchers at the Insti... started work on a 3.5 year,project to develop a n...hemical vapour deposition) diamond manufactured by...he field of CVD diamond synthesis and its,applicat...uld open up a raft of new,application areas in, fo...
Breaking Medicine News(10 mins):Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 2Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 3Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 4Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 2Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 3Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 2Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 3Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 5Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 2Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 3Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 4
...s weight pattern in France reveals that French peo...ter//. According to the ObEpi-Roche survey, almos... is affected by weight problem, with 1/3rd of it b...Obesity is on a high in France, in spite of the pe...
...th survey has revealed that Maori are almost twice...h more likely to suffer// from mental disorder gen...cted by the Health Ministry has been the first to ...ce of mental disorders among different ethnic grou...
...ding registered nurses and doctors from Doctors Me...on the Contra Costa County Board of Supervisors// ... a unanimous vote from the hospital’s board of dir...nt to file for bankruptcy. Nurse Tami Roncskevitz ...
...s suggest a short-term application of topical cort...nt for patients// with intertriginous psoriasis (I...r issue of Archives of Dermatology, one of the JAM...inflammatory skin disease. In a subset of patient...
Other Medicine News:Health News:Obesity on a high in France 2Health News:Bankruptcy forces Hospital staff to Call For County Takeover 2Health News:Bankruptcy forces Hospital staff to Call For County Takeover 3Health News:Short-Term Topical Corticosteroid May Offer Relief for Certain Type of Psoriasis 2
(Date:10/13/2008)...nd SPIRIT III Data Confirms Patients Treated, with... a Heart Attack or a Repeat Procedure Co... 13 /- Data from an indepen...T III randomized clinical,trials demonstrated that...t,System continues to deliver clinically significa...
(Date:10/13/2008)...nd to Have Higher Sensitivity and Specificity, th...d was the preferred test in all ph...t. 13 /- AT First Diagnostic LLC an,e...stic test kits, today,announced that a recent eval... of Research of the FirstVue(TM) HBSAG Test, was r...
(Date:10/13/2008)... /- Facet Solutions, Inc. today,annou...ients from its US,IDE Pilot Study. The results sho...I) scores, and an 80% reduction in Visual Analog S... President & CEO for Facet Solutions,added, "We a...us far not,only demonstrate significant pain relie...
(Date:10/12/2008)...TON, Oct. 12 /- Boston,Scie...esults from an analysis,of nearly 7,500 patients f... designed to confirm the performance of the TAXUS(...System in real-world practice. The,two-year pooled...linical,restenosis in patients with diabetes as ef...
Breaking Medicine Technology:Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years 2Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years 3Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years 4Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years 5Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests 2Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests 3Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests 4TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 2TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 3TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 4TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 5Cancer Drug Appears to Help With Aggressive MS 21744 1Cancer Drug Appears to Help With Aggressive MS 21744 2MEDRAD and PETNET Solutions Partner for Innovative FDG Delivery 21741 1MEDRAD and PETNET Solutions Partner for Innovative FDG Delivery 21741 2MEDRAD and PETNET Solutions Partner for Innovative FDG Delivery 21741 3Chindex International Inc Quantifies Fourth Quarter Charges 5970 1Chindex International Inc Quantifies Fourth Quarter Charges 5970 2Chindex International Inc Quantifies Fourth Quarter Charges 5970 3AAAS hosts June 20 conference on personalized medicine 21736 1AAAS hosts June 20 conference on personalized medicine 21736 2
...S WIRE)--Jul 9, 2007 - Neose Technologies,Inc. (N... at the,C.E. Unterberg, Towbin Emerging Growth Opp...l Hotel in New York City from July,10-12, 2007. Th....,(EDT) on Tuesday, July 10, 2007. The presentatio...a the following link:, http://www.wsw.com/webcast/...
...y 05, 2007 /PRNewswire/ -- Alfacell,Corporation to...ice,president, chief financial officer and corpora...any,s product development programs,at 8 a.m. EDT o...Towbin Emerging Growth Opportunities Conference in... be available live at,<a target="_blank" href=,"ht...
Other Medicine Technology:Alfacell Corporation to Present at C.E. Unterberg, Towbin Emerging,Growth Opportunities Conference 2
...e; is a 1-step, hand-held, point-of-care device fo...lites in human urine. The TOX/See device can dete... 3 to 8 minutes and requires only a few drops of u...ed to maximize convenience and ease of use. TOX/Se...
...e; is a 1-step, hand-held, point-of-care device fo...lites in human urine. The TOX/See device can dete... 3 to 8 minutes and requires only a few drops of u...ed to maximize convenience and ease of use. TOX/Se...
...e; is a 1-step, hand-held, point-of-care device fo...lites in human urine. The TOX/See device can dete... 3 to 8 minutes and requires only a few drops of u...ed to maximize convenience and ease of use. TOX/Se...
Sugar-Chex Linearity is a whole blood formulation designed to cover the linear reportable range of the most popular glucose meters. The product meets CAP recommendations of using a control matrix tha
Medicine Products: